Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions… (Abstract)

Low Dose Naltrexone’s Utility for Non-Cancer Centralized Pain Conditions – A Scoping Review Pain Med 11 June 2023 https://pubmed.ncbi.nlm.nih.gov/37302106/ Background: At low doses, naltrexone (LDN) has been shown to modulate inflammation through the interruption of microglial cell activation within the central nervous system. One of the most likely contributors to centralized pain is changes in […]

Opiate Antagonists for Chronic Pain… (Abstract)

Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases Biomedicines 02 June 2023 https://pubmed.ncbi.nlm.nih.gov/37371715/ Chronic pain conditions create major financial and emotional burdens that can be devastating for individuals and society. One primary source of pain is arthritis, a common inflammatory disease of the joints that […]

Repurposed drugs are cheap (News)

Repurposed drugs are cheap (News) Dr. John Campbell 09 February 2023 https://www.youtube.com/watch?v=Iw7Xz-wl5Lo Repurposed drugs are common in medicine, aspirin, morphine, viagra and prednisolone for example. After drugs have been on the market for about 15 years, their patent runs out and they can be mass produced as a very inexpensive ‘generic’ drug. Naltrexone is one […]

LDN Webinar 18 May 2022 (LDN; low dose naltrexone)

  LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com  

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease… (Abstract)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study BMJ Open 08 April 2022 https://pubmed.ncbi.nlm.nih.gov/35396307/ Introduction: Crohn’s disease (CD) is an inflammatory bowel disease (IBD). Several drugs exist to induce and maintain remission, but a significant part of the […]